Position in TRLV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,196,950
New position
Shares Held
2,665,000
first reported quarter
Ownership
1.38%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#5
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ING GROEP NV holds $98,513,048 across 6 Drug Manufacturers - Specialty & Generic names. TRLV ranks #1 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRLV |
Trulieve Cannabis Corp.
This page
|
2,665,000 | $26,196,950 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $24,650,000 | |
| 3 | ZTS |
Zoetis Inc.
|
276,942 | $19,901,052 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
102,200 | $17,224,788 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
18,800 | $10,186,404 | |
| 6 | VTRS |
Viatris Inc
|
22,283 | $353,854 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,196,950 | 2,665,000 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||